Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul;12(6):660-661.
doi: 10.1002/ueg2.12618. Epub 2024 Jun 18.

Wake up and smell the coffee: The potential of faecal volatile organic compounds in paediatric inflammatory bowel disease

Eva Vermeer  1   2   3 , Nanne K H de Boer  2   4 , Tim G J de Meij  1   2   3
Affiliations
Editorial

Wake up and smell the coffee: The potential of faecal volatile organic compounds in paediatric inflammatory bowel disease

Eva Vermeer et al. United European Gastroenterol J. 2024 Jul.
No abstract available

Keywords: Crohn's disease; IBD; inflammatory bowel disease; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Similar articles

See all similar articles

References

    1. Nagao‐Kitamoto H, Kitamoto S, Kuffa P, Kamada N. Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res. 2016;14(2):127–138. 10.5217/ir.2016.14.2.127 - DOI - PMC - PubMed
    1. Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, et al. Human gut microbiota in health and disease: unveiling the relationship. Front Microbiol. 2022;13:999001. 10.3389/fmicb.2022.999001 - DOI - PMC - PubMed
    1. Chan DK, Leggett CL, Wang KK. Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds. World J Gastroenterol. 2016;22(4):1639–1649. 10.3748/wjg.v22.i4.1639 - DOI - PMC - PubMed
    1. Mishima Y, Sartor RB. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. J Gastroenterol. 2020;55(1):4–14. 10.1007/s00535-019-01618-1 - DOI - PMC - PubMed
    1. Belnour S, Slater R, Tharmaratnam K, Auth M, Muhammed R, Spray C, et al. Faecal volatile organic compounds differ according to disease sub‐type, severity and response to treatment in paediatric inflammatory bowel disease. United Eur Gastroenterol J. 2024. - PMC - PubMed

Publication types